ELISA Kit for Epidermal Growth Factor Receptor (EGFR)

Lamie PF, El-Kalaawy AM, Abdel Latif NS, et al. Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents. Eur J Med Chem. 2021,214:113222. doi: 10.1016/j.ejmech.2021.113222

Wang Y, Liu F, OuYang S, et al. Humoral immune response to epidermal growth factor receptor in lung cancer. Immunol Res. 2021,69(1):71-80. doi: 10.1007/s12026-021-09174-8

Regiart M, Fernández-Baldo MA, Villarroel-Rocha J, et al. Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection. Anal Chim Acta. 2017,963:83-92. doi: 10.1016/j.aca.2017.01.029

Wang X, Zhang W, Tang J, et al. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway. Cell Death Dis. 2016,7(3):e2130. doi: 10.1038/cddis.2016.26

Lim Y, Yoo J, Kim MS, et al. GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands. Mol Cancer Ther. 2016,15(2):251-63. doi: 10.1158/1535-7163.MCT-15-0679

Russo AJ. Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs). J Cent Nerv Syst Dis. 2014,6:79-83. doi: 10.4137/JCNSD.S13767